CCL20 and neoplasm: The administration of NDV-MIP3α markedly attracted DCs to the tumor tissues, increased the number of IFN-γ-secreting CD8+ lymphocytes in the tumor tissues, and sufficiently primed specific CTLs to protect naive mice from a subsequent tumor challenge by adoptive transfer of splenocytes from NDV-MIP3α-injected mice.